Company Filing History:
6 out of 25 
2 out of 212 
Years Active: 2018-2024
Title: Ji Eun Jung: Innovator in Antibody-Drug Conjugates and Nuclear Resonance Fluorescence
Introduction
Ji Eun Jung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the fields of biotechnology and nuclear science, holding a total of eight patents. His innovative work focuses on antibody-drug conjugates and methods for producing technetium-99m.
Latest Patents
One of Ji Eun Jung's latest patents involves antibody-drug conjugates comprising branched linkers. This invention relates to ADCs where multiple active agents are conjugated to an antibody through branched linkers. The design allows for the coupling of two active agents to a branching unit, which is then linked to the antibody. This method enhances the efficacy of the drug delivery system. Another notable patent is a method for producing Tc-99m using nuclear resonance fluorescence. This method involves irradiating a ground-state Tc-99 nucleus with a photon beam, leading to nuclear transmutation and the production of Tc-99m.
Career Highlights
Ji Eun Jung has worked with notable companies such as Legochem Biosciences, Inc. and Korea Hydro & Nuclear Power Company Ltd. His experience in these organizations has contributed to his expertise in developing innovative solutions in his field.
Collaborations
Throughout his career, Ji Eun Jung has collaborated with talented individuals, including Yong Zu Kim and Yun Hee Park. These collaborations have fostered a creative environment that has led to groundbreaking advancements in their respective fields.
Conclusion
Ji Eun Jung's contributions to the fields of biotechnology and nuclear science exemplify the spirit of innovation. His patents and collaborations highlight his commitment to advancing technology for better healthcare solutions.